Enterprise Dose Monitoring
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) is conducting a Request for Information (RFI) to identify Small Businesses capable of providing an Enterprise Dose Monitoring System. This system aims to standardize and consolidate dose monitoring across the DHA, supporting patient safety, clinical decision-making, and mission readiness. Responses are due April 27, 2026.
Scope of Work
The DHA seeks a commercially available enterprise dose monitoring solution that offers real-time dose tracking, clinical decision support, and regulatory compliance. Key requirements include:
- Integration: Seamlessly integrate with existing systems like PACS, MHS GENESIS/Cerner, and other DHA clinical systems.
- Security & Compliance: Adhere to DoD cybersecurity, identity, and Zero-Trust policies, maintain a DHA Enterprise level ATO, and support Risk Management Framework (RMF) accreditation.
- Scalability & Operation: Support all Radiologists across CONUS and OCONUS sites, operate effectively in variable network conditions, and provide central administration and reporting.
- Advanced Functionality: Support all ionizing modalities, handle over 10 million exams/year, provide event alerts, SSDE calculation, organ dose calculations, and comprehensive analytics. Highly desired features include pregnancy status tracking and contrast tracking.
- Implementation: Deployment in a government-hosted virtual environment with standardization across the DHA Enterprise. All sites must Go-live within 12 months of contract award.
Contract & Timeline
- Type: Request for Information (RFI) / Sources Sought
- Duration: Maintenance support for 5 years post-implementation.
- Set-Aside: Small Business (determination pending RFI results). Only Small Business responses will be considered.
- Response Due: April 27, 2026, 5:00 PM ET
- Published: April 16, 2026
Submission Requirements
Interested Small Businesses must submit a Capability Statement (maximum 20 pages, 12-point font, excluding cover/administrative pages) outlining their proposed solution and a draft implementation plan. The statement should address how the firm can deliver/implement tasks outlined in Attachment 1. Submissions must include:
- Company details (Cage Code, Unique Entity Identifier (UEI), name, address, Point of Contact (POC), email, phone, structure).
- Small Business Designation status (e.g., 8(a), HUBZone, Service-Disabled Veteran Owned Small Business (SDVOSB), Women-Owned Small Business (WOSB)).
- North American Industry Classification System (NAICS) code(s) under which the company usually performs.
- Information on participation in contracting vehicles (Government-wide Acquisition Contracts (GWACs), Multiple-Award Contracts (MACs), Indefinite Delivery, Indefinite Quantity (IDIQs)) and Federal Supply Schedules (FSS). Submit an electronic PDF via email to Ms. Jennifer Sikes at jennifer.m.sikes2.civ@health.mil with the subject "Enterprise Dose Monitoring – RFI Response."
Additional Notes
This is strictly an RFI for market research and planning purposes; it is not a solicitation, and no contract will be awarded from this announcement. The information will be used to facilitate DHA decision-making and determine potential small business set-aside appropriateness.